Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of […]
QIAGEN erhält europäische IVDR-Zertifizierung für seine Medizinprodukte-Software zur Unterstützung der klinischen Entscheidungsfindung QIAGEN Clinical Insight Interpret
VENLO, Niederlande, May 14, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass […]
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated […]
Jones Soda Reports First Quarter 2024 Results
SEATTLE, May 14, 2024 (GLOBE NEWSWIRE) — Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), a […]
TSX News -
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company […]
TSX News -
Aptose Reports Results for the First Quarter 2024
TUS+VEN+HMA Triplet Protocol in 1L Therapy for Newly Diagnosed AML was Submitted to the FDA During Q1 and is Now […]
American Shared Hospital Services Reports First Quarter 2024 Financial Results
– Reports Record Projected Revenue Backlog of $210 million more than doubling following the acquisition of Rhode Island Radiation Therapy […]
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
Completed dosing in cohort one (low dose, 5.7×1014total vg) of REVEAL Phase 1/2 adolescent and adult trial with longer-term data […]
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
On track for regulatory filing for First-in-Human (FIH) study of KRRO-110 in patients with Alpha-1 Antitrypsin Deficiency (AATD) anticipated in […]
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a […]
